improving outcomes in sclc through optimal integration of the latest therapies: expert perspectives
Published 2 years ago • 1K plays • Length 1:00:27Download video MP4
Download video MP3
Similar videos
-
1:08:52
integrating new options into the sclc treatment arsenal to improve patient outcomes
-
51:59
facilitating progress in the treatment of sclc
-
1:02:02
improving outcomes in molecularly altered nsclc through precision testing and treatment
-
1:02:08
improving outcomes in molecularly altered nsclc through precision testing and treatment
-
1:24:26
assessing the impact of therapeutic advances in sclc
-
1:08:56
toward better outcomes in sclc: immunotherapy has changed the game, but where do we go next?
-
37:43
selective inhibition of oncogenic transcription and other approaches in the treatment of sclc
-
1:31:45
making the most of treatment advances in sclc
-
1:04:50
a new era has begun in the treatment of sclc: navigating novel therapeutic options and strategies
-
1:22:30
progress on the path to improving outcomes in the treatment of sclc
-
40:12
improving patient outcomes in urothelial carcinoma with novel antibody–drug conjugates
-
1:05:29
can the addition of immunotherapy to multimodal management of stage i-iii nsclc improve outcomes?
-
1:13:59
perfecting precision in nsclc practice: are you optimally integrating biomarker-driven therapy?
-
1:03:14
changing the game for es-sclc with immunotherapy and multidisciplinary collaboration
-
49:11
how to integrate perioperative immunotherapy into multimodal treatment plans in resectable nsclc
-
1:10:02
watch dr goldman, leal, and owonikoko, discuss the latest sclc updates - https://bit.ly/3jkp0l5
-
1:05:05
hcc: optimizing outcomes with new and emerging treatment approaches
-
1:31:04
immunotherapy for sclc and the "four ps" in managed care—patient, provider, pharmacy, and plan
-
52:29
improving outcomes in resectable nsclc: decisions about neoadjuvant and adjuvant immunotherapy